Cargando…

Transcatheter indirect mitral annuloplasty induces annular and left atrial remodelling in secondary mitral regurgitation

AIMS: Mitral annuloplasty using the Carillon Mitral Contour System (CMCS) reduces secondary mitral regurgitation (SMR) and leads to reverse left ventricular remodelling. The aim of this study was to evaluate the effect of the CMCS on the mitral valve annulus (MA) and left atrial volume (LAV). METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruf, Tobias Friedrich, Kreidel, Felix, Tamm, Alexander Robert, Geyer, Martin, Hahad, Omar, Zirbs, Julia Claudia, Schwidtal, Ben Luca, Beiras‐Fernandez, Andres, Witte, Klaus K., Münzel, Thomas, von Bardeleben, Ralph Stephan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373883/
https://www.ncbi.nlm.nih.gov/pubmed/32501644
http://dx.doi.org/10.1002/ehf2.12710
_version_ 1783561580226543616
author Ruf, Tobias Friedrich
Kreidel, Felix
Tamm, Alexander Robert
Geyer, Martin
Hahad, Omar
Zirbs, Julia Claudia
Schwidtal, Ben Luca
Beiras‐Fernandez, Andres
Witte, Klaus K.
Münzel, Thomas
von Bardeleben, Ralph Stephan
author_facet Ruf, Tobias Friedrich
Kreidel, Felix
Tamm, Alexander Robert
Geyer, Martin
Hahad, Omar
Zirbs, Julia Claudia
Schwidtal, Ben Luca
Beiras‐Fernandez, Andres
Witte, Klaus K.
Münzel, Thomas
von Bardeleben, Ralph Stephan
author_sort Ruf, Tobias Friedrich
collection PubMed
description AIMS: Mitral annuloplasty using the Carillon Mitral Contour System (CMCS) reduces secondary mitral regurgitation (SMR) and leads to reverse left ventricular remodelling. The aim of this study was to evaluate the effect of the CMCS on the mitral valve annulus (MA) and left atrial volume (LAV). METHODS AND RESULTS: We retrospectively evaluated the data of all patients treated with the CMCS at our centre. Using transthoracic echocardiography, MA diameters were assessed by measuring the anterolateral to posteromedial extend (ALPM) and the anterior to posterior (AP) dimensions, respectively. Also, LAV and left ventricular end‐diastolic volume (LVEDV) were assessed. Patients were examined at three time points: baseline, at 20–60 days (30dFUP), and at 9–15 months (1yFUP), using paired analysis. From July 2014 until March 2019, 75 cases of severe SMR were treated using CMCS. Cases in which other devices were used in combination (COMBO therapy, n = 35) or in which the device could not be implanted (implant failure, n = 3) were excluded, leaving 37 patients in the present analysis. Analysis at 30dFUP showed a significant reduction of 16% in the mean ALPM diameter (7.27 ± 5.40 mm) and 15% in the AP diameter (6.57 ± 5.33 mm). Analysis of LAV also showed a significant reduction of 21% (36.61 ± 82.67 mL), with no significant change in LVEDV. At 1yFUP, the reduction of both the mean ALPM diameter of 14% (6.24 ± 5.70 mm) and the mean AP diameter of 12% (5.46 ± 4.99 mm) remained significant and stable. The reduction in LAV was also maintained at 23% (37.03 ± 56.91 mL). LAV index was significantly reduced by 17% at 30dFUP (15.44 ± 40.98 mL/m(2)) and by 13% at 1yFUP (11.56 ± 31.87 mL/m(2)), respectively. LVEDV index showed no significant change at 30dFUP and a non‐significant 10% reduction at 1yFUP (17.75 ± 58.79 mL/m(2)). CONCLUSIONS: The CMCS successfully treats symptomatic SMR with a stable reduction of not only the AP diameter of the MA, but the current study also demonstrates an additional reduction of the ALPM dimension at both 30dFUP and 1yFUP. We have also shown for the first time that LAV and LAV index are significantly reduced at both 30dFUP and 1yFUP and a non‐significant positive remodelling of the LVEDV. This positive left atrial remodelling has not been looked for and demonstrated in earlier randomized studies of CMCS.
format Online
Article
Text
id pubmed-7373883
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-73738832020-07-22 Transcatheter indirect mitral annuloplasty induces annular and left atrial remodelling in secondary mitral regurgitation Ruf, Tobias Friedrich Kreidel, Felix Tamm, Alexander Robert Geyer, Martin Hahad, Omar Zirbs, Julia Claudia Schwidtal, Ben Luca Beiras‐Fernandez, Andres Witte, Klaus K. Münzel, Thomas von Bardeleben, Ralph Stephan ESC Heart Fail Original Research Articles AIMS: Mitral annuloplasty using the Carillon Mitral Contour System (CMCS) reduces secondary mitral regurgitation (SMR) and leads to reverse left ventricular remodelling. The aim of this study was to evaluate the effect of the CMCS on the mitral valve annulus (MA) and left atrial volume (LAV). METHODS AND RESULTS: We retrospectively evaluated the data of all patients treated with the CMCS at our centre. Using transthoracic echocardiography, MA diameters were assessed by measuring the anterolateral to posteromedial extend (ALPM) and the anterior to posterior (AP) dimensions, respectively. Also, LAV and left ventricular end‐diastolic volume (LVEDV) were assessed. Patients were examined at three time points: baseline, at 20–60 days (30dFUP), and at 9–15 months (1yFUP), using paired analysis. From July 2014 until March 2019, 75 cases of severe SMR were treated using CMCS. Cases in which other devices were used in combination (COMBO therapy, n = 35) or in which the device could not be implanted (implant failure, n = 3) were excluded, leaving 37 patients in the present analysis. Analysis at 30dFUP showed a significant reduction of 16% in the mean ALPM diameter (7.27 ± 5.40 mm) and 15% in the AP diameter (6.57 ± 5.33 mm). Analysis of LAV also showed a significant reduction of 21% (36.61 ± 82.67 mL), with no significant change in LVEDV. At 1yFUP, the reduction of both the mean ALPM diameter of 14% (6.24 ± 5.70 mm) and the mean AP diameter of 12% (5.46 ± 4.99 mm) remained significant and stable. The reduction in LAV was also maintained at 23% (37.03 ± 56.91 mL). LAV index was significantly reduced by 17% at 30dFUP (15.44 ± 40.98 mL/m(2)) and by 13% at 1yFUP (11.56 ± 31.87 mL/m(2)), respectively. LVEDV index showed no significant change at 30dFUP and a non‐significant 10% reduction at 1yFUP (17.75 ± 58.79 mL/m(2)). CONCLUSIONS: The CMCS successfully treats symptomatic SMR with a stable reduction of not only the AP diameter of the MA, but the current study also demonstrates an additional reduction of the ALPM dimension at both 30dFUP and 1yFUP. We have also shown for the first time that LAV and LAV index are significantly reduced at both 30dFUP and 1yFUP and a non‐significant positive remodelling of the LVEDV. This positive left atrial remodelling has not been looked for and demonstrated in earlier randomized studies of CMCS. John Wiley and Sons Inc. 2020-06-05 /pmc/articles/PMC7373883/ /pubmed/32501644 http://dx.doi.org/10.1002/ehf2.12710 Text en © 2020 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research Articles
Ruf, Tobias Friedrich
Kreidel, Felix
Tamm, Alexander Robert
Geyer, Martin
Hahad, Omar
Zirbs, Julia Claudia
Schwidtal, Ben Luca
Beiras‐Fernandez, Andres
Witte, Klaus K.
Münzel, Thomas
von Bardeleben, Ralph Stephan
Transcatheter indirect mitral annuloplasty induces annular and left atrial remodelling in secondary mitral regurgitation
title Transcatheter indirect mitral annuloplasty induces annular and left atrial remodelling in secondary mitral regurgitation
title_full Transcatheter indirect mitral annuloplasty induces annular and left atrial remodelling in secondary mitral regurgitation
title_fullStr Transcatheter indirect mitral annuloplasty induces annular and left atrial remodelling in secondary mitral regurgitation
title_full_unstemmed Transcatheter indirect mitral annuloplasty induces annular and left atrial remodelling in secondary mitral regurgitation
title_short Transcatheter indirect mitral annuloplasty induces annular and left atrial remodelling in secondary mitral regurgitation
title_sort transcatheter indirect mitral annuloplasty induces annular and left atrial remodelling in secondary mitral regurgitation
topic Original Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373883/
https://www.ncbi.nlm.nih.gov/pubmed/32501644
http://dx.doi.org/10.1002/ehf2.12710
work_keys_str_mv AT ruftobiasfriedrich transcatheterindirectmitralannuloplastyinducesannularandleftatrialremodellinginsecondarymitralregurgitation
AT kreidelfelix transcatheterindirectmitralannuloplastyinducesannularandleftatrialremodellinginsecondarymitralregurgitation
AT tammalexanderrobert transcatheterindirectmitralannuloplastyinducesannularandleftatrialremodellinginsecondarymitralregurgitation
AT geyermartin transcatheterindirectmitralannuloplastyinducesannularandleftatrialremodellinginsecondarymitralregurgitation
AT hahadomar transcatheterindirectmitralannuloplastyinducesannularandleftatrialremodellinginsecondarymitralregurgitation
AT zirbsjuliaclaudia transcatheterindirectmitralannuloplastyinducesannularandleftatrialremodellinginsecondarymitralregurgitation
AT schwidtalbenluca transcatheterindirectmitralannuloplastyinducesannularandleftatrialremodellinginsecondarymitralregurgitation
AT beirasfernandezandres transcatheterindirectmitralannuloplastyinducesannularandleftatrialremodellinginsecondarymitralregurgitation
AT witteklausk transcatheterindirectmitralannuloplastyinducesannularandleftatrialremodellinginsecondarymitralregurgitation
AT munzelthomas transcatheterindirectmitralannuloplastyinducesannularandleftatrialremodellinginsecondarymitralregurgitation
AT vonbardelebenralphstephan transcatheterindirectmitralannuloplastyinducesannularandleftatrialremodellinginsecondarymitralregurgitation